Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2003-10-06 / Br. J. Cancer 2003 Oct;89(7):1172-9Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2003-10-01 / Haematologica 2003 Oct;88(10):1139-49Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells
/in Breast Cancer, Dendritic Cells, International Publications /von 2003-10-01 / Clin. Cancer Res. 2003 Oct;9(12):4376-86Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2003-10-01 / Melanoma Res. 2003 Oct;13(5):521-30Thermal regulation of dendritic cell activation and migration from skin explants
/in Dendritic Cells, Hyperthermia, International Publications /von 2003-09-01 / Int J Hyperthermia 2003 Sep-Oct;19(5):520-33Dendritic cell-based vaccines in breast and gynaecologic cancer
/in Breast Cancer, Cervical Cancer, Dendritic Cells, International Publications, Ovarian Cancer /von 2003-09-01 / Anticancer Res. 2003 Sep-Oct;23(5b):4293-303Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function
/in Dendritic Cells, International Publications /von 2003-09-01 / J. Immunol. 2003 Sep;171(5):2366-73The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications /von 2003-08-01 / J. Neurooncol. 2003 Aug-Sep;64(1-2):161-76Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients
/in Cervical Cancer, Dendritic Cells, International Publications /von 2003-07-30 / J. Cancer Res. Clin. Oncol. 2003 Sep;129(9):521-30IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de